Our phase 1 trial, the first study to test mRNA vaccines in pancreatic cancer, opened in November 2019 with the goal to test the safety of custom mRNA vaccines after surgery in 20 patients with ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published Wednesday. Fewer than 13% of people live more than five years after ...

An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine autogene cevumeran continues to show potential to stimulate an immune response ...

She credits an experimental therapy – a personalized cancer vaccine – being tested by BioNTech, one of the companies that helped make the mRNA vaccines for Covid-19.

Credit: Getty Images. Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem. Pancreatic cancer has proven resistant to ...

This is how the recent pancreatic cancer mRNA vaccine was developed. The pharmaceutical company BioNtech created personalised mRNA vaccines for 16 participants using cells from their recently ...

The development of the Covid vaccine helped super-charge what many researchers are calling an "mRNA-Renaissance" that could see new vaccines prevent everything from cancer to the plague.

Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it. By Benjamin Mueller Five years ...

Personalized mRNA vaccines show promise as pancreatic cancer treatment, a phase 1 clinical trial published Wednesday in ...

An mRNA vaccine that programs the body to fight pancreatic cancer shows early promise ... Pancreatic cancer is one of the most lethal malignancies, fatal in 88% of patients.